Rivastigmine patch ameliorates depression in mild AD: preliminary evidence from a 6-month open-label observational study
G Spalletta, W Gianni, F Giubilei… - Alzheimer Disease & …, 2013 - journals.lww.com
Here we investigated the effect of the rivastigmine patch alone on depression in 50 mild
Alzheimer's Disease (AD) patients with comorbid major depressive episode (MDE). First
diagnosis acetyl-cholinesterase inhibitor and psychoactive drug-free outpatients (n= 50)
were recruited in memory clinics and reassessed after 3 and 6 months. Global cognitive
functioning, depressive symptoms and MDE frequency were evaluated with the Mini Mental
State Examination, the CERAD Dysphoria scale and the modified DSM-IV criteria for MDE in …
Alzheimer's Disease (AD) patients with comorbid major depressive episode (MDE). First
diagnosis acetyl-cholinesterase inhibitor and psychoactive drug-free outpatients (n= 50)
were recruited in memory clinics and reassessed after 3 and 6 months. Global cognitive
functioning, depressive symptoms and MDE frequency were evaluated with the Mini Mental
State Examination, the CERAD Dysphoria scale and the modified DSM-IV criteria for MDE in …
以上显示的是最相近的搜索结果。 查看全部搜索结果